معرفی
Michael Lazarus, PhD, is an Associate Professor in the Department of Pharmacological Sciences at Weill Cornell Medicine. His research focuses on structural biology, enzymology, and metabolic disorders, particularly in understanding disease mechanisms and developing therapeutic strategies. He holds a BS from Yale University and a PhD from Harvard University.
- Education:
- BS, Yale University
- PhD, Harvard University
- Research Interests: Cancer Biology, Disease Mechanisms & Therapeutics, Enzyme Structure/Function, Metabolic Disorders, and Drug Discovery.
His recent work includes structural studies of enzymes involved in metabolic diseases like Glutaric Aciduria Type 1 and the development of inhibitors targeting cellular pathways. Lazarus has received major awards such as the 2020 Irma T. Hirschl Career Scientist Award and the 2017 NIH R35 Award.
- Awards:
- 2020 Irma T. Hirschl Career Scientist Award
- 2017 NIH R35 Maximizing Investigators’ Research Award
- 2016 Mallinckrodt Foundation Grant Award
Publications span structural biology, enzymology, and drug discovery, with key contributions to understanding O-GlcNAc transferase, bacterial RNases, and metabolic enzyme inhibitors. His lab is also involved in translational research for cancer and lysosomal storage diseases.
